Hepato Papers – “Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration”
9 de março de 2023
![vivian_destaque.png](https://sbhepatologia.org.br/wp-content/uploads/2023/03/vivian_destaque.png)
A hepatologista Dra. Vivian Rotman comenta o novo artigo para o Hepato Papers: Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
Confira: